REGN vs TILE · P/E 14, rev $14.34B vs P/E 14, rev $1.32B
Regeneron Pharmaceuticals Inc (REGN) versus Interface Inc (TILE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Interface Inc (TILE) is a furnishings, fixtures & appliances company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TILE revenue for 2024-12-29 was $1.32B. Net income was $86.9M. Revenue was up 4.3% from 2023-12-31 to 2024-12-29. TILE currently screens at market cap $1.80B and trailing P/E 14.5.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TILE currently screens at market cap $1.80B and trailing P/E 14.5.
Not investment advice. Open the REGN and TILE stock pages for the full models.
Not investment advice.